NSE · GUFICBIO
Gufic Biosciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#904
of 5,072 stocks
▼ 91W
Peak #895 · 21 Sep 2026
Gufic Biosciences Limited is a smallcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 72%, and is growing revenue at a solid clip.
Market Cap
4,249.49 Cr
P/E Ratio
66.21
P/B Ratio
6.39
ROE
9.66%
ROCE
14.94%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 260.82 Cr | 251.82 Cr | 231.41 Cr | 237.05 Cr |
| Net Profit | 22.31 Cr | 21.90 Cr | 12.42 Cr | 16.82 Cr |
| EPS | 2.22 | 2.18 | 1.24 | 1.68 |
| Operating Profit | 39.36 Cr | 38.39 Cr | 26.08 Cr | 32.19 Cr |
Shareholding pattern
Promoter
72.50%
Public
27.50%
Mutual fund holdings
₹122.75
Cr total
10
Schemes
5
Fund Houses
₹122.75 Cr
Total Exposure
ICICI Prudential Mutual Fund₹65.24 Cr (53.1%)
Bank of India Mutual Fund₹40.77 Cr (33.2%)
SBI Mutual Fund₹16.65 Cr (13.6%)
Quantum Mutual Fund₹0.06 Cr (0.0%)
Motilal Oswal Mutual Fund₹0.03 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 28 Aug 2026 | Dividend | Dividend - Re 0.10 Per Share |
| 22 Sep 2025 | Dividend | Dividend - Re 0.10 Per Share |
| 17 Sep 2024 | Dividend | Annual General Meetingdividend - Re 0.10 Per Share |
| 21 Sep 2023 | Dividend | Annual General Meeting/Dividend - Re 0.10 Per Share |
| 24 Aug 2022 | Dividend | Annual General Meeting/Dividend - Rs 0.10 Per Sh |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.